Antibiotic Treatment for Group A Streptococcal Bacteremia

First-Line Treatment Regimen

The American College of Physicians recommends a combination of intravenous penicillin G plus clindamycin as the first-line treatment for Group A Streptococcal bacteremia, with penicillin G 2-4 million units IV every 4-6 hours PLUS clindamycin 600-900 mg IV every 8 hours 1, 2
The Infectious Diseases Society of America suggests that the combination therapy with both penicillin and clindamycin is critical as clindamycin suppresses streptococcal toxin and cytokine production, while penicillin provides bactericidal activity 1
The recommended duration of IV antibiotics is until the patient has demonstrated obvious clinical improvement and fever has been absent for 48-72 hours 1

The American Academy of Family Physicians states that clindamycin is superior to penicillin alone in animal models and observational studies for invasive Group A streptococcal infections, with a strength of evidence rated as high 1, 2
Clindamycin inhibits protein synthesis and suppresses bacterial toxin production, which is particularly important in cases of streptococcal toxic shock syndrome, with a moderate level of evidence 1
Penicillin should be added to clindamycin because of potential resistance of Group A streptococci to clindamycin, although resistance rates in the US are low, with a low level of evidence 1, 2

For patients with severe penicillin allergy, the Infectious Diseases Society of America recommends using vancomycin, linezolid, quinupristin/dalfopristin, or daptomycin in place of penicillin, with a high strength of evidence 1, 2
The American Academy of Family Physicians suggests continuing clindamycin as part of the regimen unless the patient has clindamycin allergy, with a moderate level of evidence 1

The American Academy of Family Physicians recommends penicillin V 250 mg four times daily or 500 mg twice daily for adults, with a moderate level of evidence 3, 5
Amoxicillin 500 mg twice daily for adults is also recommended, with a low level of evidence due to potential bias in the study 3

The Infectious Diseases Society of America states that surgical intervention is essential if there is evidence of necrotizing fasciitis or other deep tissue infection, with a high strength of evidence 1, 2
For streptococcal toxic shock syndrome, some experts recommend consideration of intravenous immunoglobulin (IVIG), though evidence for this is not conclusive, with a low level of evidence 1, 2
Repeat blood cultures should be performed to ensure clearance of bacteremia, with a moderate level of evidence 2
Patients with persistent bacteremia should undergo imaging to identify undrained foci of infection, with a moderate level of evidence 2

Monotherapy with penicillin alone may be inadequate for severe invasive Group A streptococcal infections due to the "Eagle effect" (large inoculum effect), with a high strength of evidence 1
Macrolides (such as azithromycin) should be avoided as primary therapy for invasive Group A streptococcal infections due to increasing resistance rates, with a moderate level of evidence 3
Delayed recognition and treatment of necrotizing soft tissue infections can lead to significantly increased morbidity and mortality, with a high strength of evidence 1, 2